177 related articles for article (PubMed ID: 27268613)
1. Targeting HSP90 Gene Expression with 17-DMAG Nanoparticles in Breast Cancer Cells.
Mellatyar H; Talaei S; Nejati-Koshki K; Akbarzadeh A
Asian Pac J Cancer Prev; 2016; 17(5):2453-7. PubMed ID: 27268613
[TBL] [Abstract][Full Text] [Related]
2. Comparison of inhibitory effect of 17-DMAG nanoparticles and free 17-DMAG in HSP90 gene expression in lung cancer.
Mellatyar H; Akbarzadeh A; Rahmati M; Ghalhar MG; Etemadi A; Nejati-Koshki K; Zarghami N; Barkhordari A
Asian Pac J Cancer Prev; 2014; 15(20):8693-8. PubMed ID: 25374192
[TBL] [Abstract][Full Text] [Related]
3. An activated JAK/STAT3 pathway and CD45 expression are associated with sensitivity to Hsp90 inhibitors in multiple myeloma.
Lin H; Kolosenko I; Björklund AC; Protsyuk D; Österborg A; Grandér D; Tamm KP
Exp Cell Res; 2013 Mar; 319(5):600-11. PubMed ID: 23246572
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the inhibitory effect of nano-encapsulated helenalin and free helenalin on telomerase gene expression in the breast cancer cell line, by real-time PCR.
Kordi S; Zarghami N; Akbarzadeh A; Rahmati YM; Ghasemali S; Barkhordari A; Tozihi M
Artif Cells Nanomed Biotechnol; 2016; 44(2):695-703. PubMed ID: 25435410
[TBL] [Abstract][Full Text] [Related]
5. Comparison of inhibitory effects of 17-AAG nanoparticles and free 17-AAG on HSP90 gene expression in breast cancer.
Ghalhar MG; Akbarzadeh A; Rahmati M; Mellatyar H; Dariushnejad H; Zarghami N; Barkhordari A
Asian Pac J Cancer Prev; 2014; 15(17):7113-8. PubMed ID: 25227799
[TBL] [Abstract][Full Text] [Related]
6. 17-DMAG-loaded nanofibrous scaffold for effective growth inhibition of lung cancer cells through targeting HSP90 gene expression.
Mellatyar H; Talaei S; Pilehvar-Soltanahmadi Y; Dadashpour M; Barzegar A; Akbarzadeh A; Zarghami N
Biomed Pharmacother; 2018 Sep; 105():1026-1032. PubMed ID: 30021337
[TBL] [Abstract][Full Text] [Related]
7. The apoptotic effect and associated signalling of HSP90 inhibitor 17-DMAG in hepatocellular carcinoma cells.
Leng AM; Liu T; Yang J; Cui JF; Li XH; Zhu YN; Xiong T; Zhang G; Chen Y
Cell Biol Int; 2012 Oct; 36(10):893-9. PubMed ID: 22694478
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models.
Smith V; Sausville EA; Camalier RF; Fiebig HH; Burger AM
Cancer Chemother Pharmacol; 2005 Aug; 56(2):126-37. PubMed ID: 15841378
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of RIP expression by 17-dimethylaminoethylamino-17-demethoxygeldanamycin promotes TRAIL-induced apoptosis in breast tumor cells.
Palacios C; López-Pérez AI; López-Rivas A
Cancer Lett; 2010 Jan; 287(2):207-15. PubMed ID: 19632771
[TBL] [Abstract][Full Text] [Related]
10. The effects of Hsp90 expression alteration on spinal metastases of breast carcinoma.
Yan W; Xiao J; Liu T; Huang W; Yang X; Wu Z; Huang Q; Qian M
Tumour Biol; 2013 Jun; 34(3):1391-7. PubMed ID: 23456764
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of heat shock protein 90 attenuates post‑angioplasty intimal hyperplasia.
Kassem MM; Muqri F; Dacosta M; Bruch D; Gahtan V; Maier KG
Mol Med Rep; 2020 Apr; 21(4):1959-1964. PubMed ID: 32319637
[TBL] [Abstract][Full Text] [Related]
12. Preparation and Evaluation of Chrysin Encapsulated in PLGA- PEG Nanoparticles in the T47-D Breast Cancer Cell Line.
Mohammadinejad S; Akbarzadeh A; Rahmati-Yamchi M; Hatam S; Kachalaki S; Zohreh S; Zarghami N
Asian Pac J Cancer Prev; 2015; 16(9):3753-8. PubMed ID: 25987033
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
Schwock J; Pham NA; Cao MP; Hedley DW
Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
[TBL] [Abstract][Full Text] [Related]
14. Non-benzoquinone geldanamycin analogs trigger various forms of death in human breast cancer cells.
Zhang Z; Li HM; Zhou C; Li Q; Ma L; Zhang Z; Sun Y; Wang L; Zhang X; Zhu B; Hong YS; Wu CZ; Liu H
J Exp Clin Cancer Res; 2016 Sep; 35(1):149. PubMed ID: 27658586
[TBL] [Abstract][Full Text] [Related]
15. 17-AAG and 17-DMAG-induced inhibition of cell proliferation through B-Raf downregulation in WT B-Raf-expressing uveal melanoma cell lines.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2348-56. PubMed ID: 18281615
[TBL] [Abstract][Full Text] [Related]
16. Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via beta-catenin/TCF7L2 pathway in adult T cell leukemia cells.
Kurashina R; Ohyashiki JH; Kobayashi C; Hamamura R; Zhang Y; Hirano T; Ohyashiki K
Cancer Lett; 2009 Oct; 284(1):62-70. PubMed ID: 19464103
[TBL] [Abstract][Full Text] [Related]
17. [Enhancement of HER-2 degradation by carbamazepine in breast cancer SKBR-3 cell line].
Meng QW; Zhao CH; Xi YH; Cai L; Sun LC; Sui GJ
Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):503-6. PubMed ID: 17147113
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of 17-demethoxy 17-[[(2-dimethylamino)ethyl]amino]geldanamycin (17DMAG, NSC 707545) in C.B-17 SCID mice bearing MDA-MB-231 human breast cancer xenografts.
Eiseman JL; Lan J; Lagattuta TF; Hamburger DR; Joseph E; Covey JM; Egorin MJ
Cancer Chemother Pharmacol; 2005 Jan; 55(1):21-32. PubMed ID: 15338192
[TBL] [Abstract][Full Text] [Related]
19. In vitro study comparing the efficacy of the water-soluble HSP90 inhibitors, 17-AEPGA and 17-DMAG, with that of the non‑water-soluble HSP90 inhibitor, 17-AAG, in breast cancer cell lines.
Ghadban T; Jessen A; Reeh M; Dibbern JL; Mahner S; Mueller V; Wellner UF; Güngör C; Izbicki JR; Vashist YK
Int J Mol Med; 2016 Oct; 38(4):1296-302. PubMed ID: 27498942
[TBL] [Abstract][Full Text] [Related]
20. Novel Hsp90 inhibitor FW-04-806 displays potent antitumor effects in HER2-positive breast cancer cells as a single agent or in combination with lapatinib.
Huang W; Wu QD; Zhang M; Kong YL; Cao PR; Zheng W; Xu JH; Ye M
Cancer Lett; 2015 Jan; 356(2 Pt B):862-71. PubMed ID: 25449780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]